Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Phosphorylation of the type II transmembrane serine protease, TMPRSS13, in hepatocyte growth factor activator inhibitor-1 and -2-mediated cell-surface localization.

Murray AS, Varela FA, Hyland TE, Schoenbeck AJ, White JM, Tanabe LM, Todi SV, List K.

J Biol Chem. 2017 Sep 8;292(36):14867-14884. doi: 10.1074/jbc.M117.775999. Epub 2017 Jul 14.

PMID:
28710277
2.

TMPRSS4: an emerging potential therapeutic target in cancer.

de Aberasturi AL, Calvo A.

Br J Cancer. 2015 Jan 6;112(1):4-8. doi: 10.1038/bjc.2014.403. Epub 2014 Sep 9. Review.

3.

TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition.

Madsen DH, Szabo R, Molinolo AA, Bugge TH.

Biochem J. 2014 Aug 1;461(3):487-95. doi: 10.1042/BJ20140337.

4.

Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea.

Faller N, Gautschi I, Schild L.

PLoS One. 2014 Apr 10;9(4):e94267. doi: 10.1371/journal.pone.0094267. eCollection 2014.

5.

Membrane-anchored serine proteases in health and disease.

Antalis TM, Bugge TH, Wu Q.

Prog Mol Biol Transl Sci. 2011;99:1-50. doi: 10.1016/B978-0-12-385504-6.00001-4. Review.

6.

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.

Okumura Y, Takahashi E, Yano M, Ohuchi M, Daidoji T, Nakaya T, Böttcher E, Garten W, Klenk HD, Kido H.

J Virol. 2010 May;84(10):5089-96. doi: 10.1128/JVI.02605-09. Epub 2010 Mar 10.

7.

Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.

Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M.

J Mol Genet Med. 2008 Nov 29;3(1):167-75.

8.

Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.

Szabo R, Kosa P, List K, Bugge TH.

Am J Pathol. 2009 Jun;174(6):2015-22. doi: 10.2353/ajpath.2009.090053. Epub 2009 Apr 23.

9.

Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.

Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, López-Otín C.

Haematologica. 2009 Jun;94(6):840-9. doi: 10.3324/haematol.2008.001867. Epub 2009 Apr 18. Review.

10.
12.

Membrane associated proteases and their inhibitors in tumour angiogenesis.

Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM.

J Clin Pathol. 2004 Jun;57(6):577-84. Review.

13.

Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues.

Hooper JD, Campagnolo L, Goodarzi G, Truong TN, Stuhlmann H, Quigley JP.

Biochem J. 2003 Aug 1;373(Pt 3):689-702.

Supplemental Content

Support Center